Abstract
The prevalence of heart failure (HF) is approximately 1–2% of the adult population in developed countries, rising to ≥ 10% among people over 70. The common symptoms of HF include shortness of breath, ankle swelling and fatigue, determined by a reduced cardiac output. Multimodality imaging is crucial to define HF etiology, determine prognosis and guiding tailored treatments. Echocardiography is the most widely used imaging modality and maintains a pivotal role in the initial diagnostic work-up and in the follow-up of HF patients. Cardiac magnetic resonance (CMR) may support the morpho-functional assessment provided by echocardiography when the acoustic window is limited or a gold standard evaluation is required. Furthermore, CMR is frequently used due to the unmatched capability to characterize myocardial structure. Coronary computed tomography angiography has become the non-invasive imaging of choice to diagnose or rule-out coronary artery disease, acquiring remarkable importance in the management of HF patients. Moreover, emerging capabilities of CT-based tissue characterization may be useful, especially when CMR is contraindicated. Finally, chest CT may contribute to precisely define the framework of HF patients, revealing new insight about cardiopulmonary pathophysiological interactions with potential high prognostic value.
Similar content being viewed by others
References
Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93:1137–1146
Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202
Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Leiro MC, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L (2013) EURObservational research programme: regional differences and 1-year follow-up results of the heart failure pilot Survey (ESC-HF Pilot). Eur J Heart Fail 15:808–817
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) The task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC), ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200
Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, Faletra FF, Franke A, Hung J, Perez de Isla L, Kamp O, Kasprzak JD, Lancellotti P, Marwick TH, McCulloch ML, Monaghan MJ, Nihoyannopoulos P, Pandian NG, Pellikka PA, Pepi M, Roberson DA, Shernan SK, Shirali GS, Sugeng L, TenCate FJ, Vannan MA, Zamorano JL, Zoghbi WA (2012) EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr 25:3–46
Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, Pfeffer MA (2005) Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112(24):3738–3744
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, Flachskampf FA, Gillebert TC, Klein AL, Lancellotti P, Marino P, Oh JK, AlexandruPopescu B, Waggoner AD (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 17(12):1321–1360
Markman TM, Habibi M, Venketash BA, Zareian M, Wu C, Heckbert SR, Bluemke DA, Lima JAC (2017) Association of left atrial structure and function and incident cardiovascular disease in patients with diabetes mellitus: results from multi-ethnic study of atherosclerosis(MESA). Eur Heart J Cardiovasc Imaging 18(10):1138–1144
Merlo M, Gobbo M, Stolfo D, Losurdo P, Ramani F, Barbati G, Pivetta A, Di Lenarda A, Anzini M, Gigli M, Pinamonti B, Sinagra G (2016) The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging 9(9):1034–1042
Anavekar NS, Chareonthaitawee P, Narula J, Gersh BJ (2016) Revascularization in patients with severe left ventricular dysfunction: Is the assessment of viability still viable? J Am Coll Cardiol 67(24):2874–2887
Cusmà Piccione M, Zito C, Khandheria B, Madaffari A, Oteri A, Falanga G, Donato D, D’Angelo M, Carerj ML, Di Bella G, Imbalzano E, Pugliatti P, Carerj S (2017) Cardiovascular maladaptation to exercise in young hypertensive patients. Int J Cardiol 232:280–288
Zito C, Longobardo L, Citro R, Galderisi M, Oreto L, Carerj ML, Manganaro R, Cusmà-Piccione M, Todaro MC, Di Bella G, Imbalzano E, Khandheria BK, Carerj S (2018) Ten years of 2D longitudinal strain for early myocardial dysfunction detection: a clinical overview. Biomed Res IntDec 5(2018):8979407
Zito C, Mohammed M, Todaro MC, Khandheria BK, Cusmà-Piccione M, Oreto G, Pugliatti P, Abusalima M, Antonini-Canterin F, Vriz O, Carerj S (2014) Interplay between arterial stiffness and diastolic function: a marker of ventricular-vascular coupling. J Cardiovasc Med (Hagerstown) 15(11):788–796
Picano E, Scali MC, Ciampi Q, Lichtenstein D (2018) JACC Cardiovasc Imaging 11:1692–1705
Sengupta PP, Kramer CM, Narula J, Vasken Dilsizian M (2017) The potential of clinical phenotyping of heart failure with imaging biomarkers for guiding therapies: a focused update. JACC Cardiovasc Imaging 10:1056–1071
Francone M, Carbone I, Agati L, Bucciarelli Ducci C, Mangia M, Iacucci I, Catalano C, Passariello R (2011) Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease. Radiol Med 116(1):32–46
Bax JJ, Di Carli M, Narula J, Delgado V (2018) Multimodality imaging in ischaemic heart failure. The Lancet 393(10175):1056–1070
Francone M (2014) Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance. ISRN radiology 2014:365404. https://doi.org/10.1155/2014/365404
Di Cesare E, Cademartiri F, Carbone I, Carriero A, Centonze M, De Cobelli F et al (2013) Clinical indications for the use of cardiac MRI. By the SIRM study group on cardiac imaging. Radiol Med 118:752–798
Gimelli A, Lancellotti P, Badano LP, Lombardi L, Gerber B, Plein D, Neglia D, Edvardsen T, Kitsiou Anastasia, Scholte AJHA, Schroder S, Cosyns B, Gargiulo P, Zamorano JL, Perrone-Filardi P (2014) Non-invasive cardiac imaging evaluation of patients with chronic systolic heart failure: a report from the European Association of Cardiovascular Imaging (EACVI). Eur Heart J 35:3417–3425
Kraigher-krainer E, Shah AM, Gupta DK et al (2014) Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. JACC 63(5):447–456
Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26(15):1461–1474
Felker GM, Shaw LK, Connor CMO, Carolina N (2002) A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39:210–218
Verhaert D, Thavendiranathan P, Giri S, Raman SV (2011) Direct T2 quantification of myocardial edema in acute ischemic injury. JCMG 4:269–278
Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MTD, Hawkins PN, Neubauer S, Moon JC (2014) Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JCMG 6:488–497
Shah DJ, Kim HW, James O et al (2013) Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA 309(9):909–918
Su MYM, Lin LY, Tseng YHE, Chang CC, Wu CK, Tseng IWY (2015) CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF. JACC Cardiovasc Imaging 7(10):991–997
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NAM III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. NEJM 361(14):1329–1338
Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ, Tokuda M, Daly CA, Tedrow UB, Stevenson WG, Jerosch-He M (2013) CMR Quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC: Cardiovascolar Imaging 6(9):944–954
Cheong BYC, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, Elayda MacArthur A, Lee VV, Scott D, Flamm M (2009) Prognostic significance of delayed-enhancement magnetic resonance imaging survival of 857 patients with and without left ventricular dysfunction. Circulation 120(21):2069–2076
Pradella S, Grazzini G, Brandani M, Calistri L, Nardi C, Mori F, Miele V, Colagrande S (2019) Cardiac magnetic resonance in patients with mitral valve prolapse: focus on late gadolinium enhancement and T1 mapping. Eur Radiol 29(3):1546–1554. https://doi.org/10.1007/s00330-018-5634-5Epub 2018 Aug 7
Kadish AH, Bello D, Finn JP, Bonow RO, Schaechter A, Subacius H, Albert C, Daubert JP, Fonseca CG, Goldberger JJ (2009) Rationale and design for the defibrillators to reduce risk by magnetic resonance imaging evaluation (DETERMINE) trial. J Cardiovasc Electrophysiol 20(9):982–987
Buckley O, DiCarli M (2011) Predicting benefit from revascularization in patients with is- chemic heart failure: imaging of myocardial ischemia and viability. Circulation 123:444–450
Carrabba N, Berteotti M, Taborchi G, Ciatti F, Acquafresca M, Moroni M, Migliorini A, Miele V, Marchionni N, Valenti R (2019) Integration of CTA in the diagnostic workup of new onset chest pain in clinical practice. Biomed Res Int 2019:2647079. https://doi.org/10.1155/2019/2647079
Di Cesare E, Gennarelli A, Di Sibio A, Felli V, Splendiani A, Gravina GL et al (2015) Image quality and radiation dose of single heartbeat 640-slice coronary CT angiography: a comparison between patients with chronic atrial fibrillation and subjects in normal sinus rhythm by propensity analysis. Eur J Radiol 84:631–636
Vorre MM, Abdulla J (2013) Diagnostic accuracy and radiation Dose of cT coronary angiography in atrial fibrillation: systematic review and meta-analysis. Radiology 267(2):376–386
ten Kate GJ, Caliskan K, Dedic A, Meijboom WB, Neefjes LA, Manintveld OC, Krenning BJ, Ouhlous M, Nieman K, Krestin GP, de Feyter PJ (2013) Computed tomography coronary imaging as a gatekeeper for invasive coronary angiography in patients with newly diagnosed heart failure of unknown aetiology. Eur J Heart Fail 15(9):1028–1034
Rocha-Filho JA, Blankstein R, Shturman LD, Bezerra HG, Okada DR, Rogers IS, Ghoshhajra B, Hoffmann U, Feuchtner G, Mamuya WS, Brady TJ, Cury RC (2010) Incremental value of adenosine-induced stress myocardial perfusion imaging with dual-source CT at cardiac CT angiography. Radiology 254(2):410–419
George RT, Mehra VC, Chen MY, Kitagawa K, Arbab-Zadeh A, Miller JM, Matheson MB, Vavere AL, Kofoed KF, Rochitte CE, Dewey M, Yaw TS, Niinuma H, Brenner W, Cox C, Clouse ME, Lima JA, Di Carli M (2014) Myocardial CT perfusion imaging and SPECT for the diagnosis of coronary artery disease: a head-to-head comparison from the CORE320 multicenter diagnostic performance study. Radiology 272(2):407–416
Takx RAP, Moscariello A, Schoepf UJ, Barraza JMJ, Nance JWJ, Bastarrika G, Henzler T (2012) Quantification of left and right ventricular function and myocardial mass: comparison of low-radiation dose 2nd generation dual-source CT and cardiac MRI. Eur J Radiol 81(4):e598–e604
Esposito A, Palmisano A, Antunes S, Colantoni C, Rancoita P, Vignale D, Baratto F, Della Bella P, Del Maschio A, De Cobelli F (2018) Assessment of remote myocardium heterogeneity in patients with ventricular tachycardia using texture analysis of late iodine enhancement (LIE) cardiac computed tomography (cCT) images. Mol Imaging Biol 20(5):816–825
Ohta Y, Kitao S, Yunaga H, Fujii S, Mukai N, Yamamoto K, Ogawa T (2018) Myocardial delayed enhancement CT for the evaluation of heart failure: comparison to MRI. Radiology 288(3):682–691
Esposito A, Palmisano A, Antunes S, Maccabelli G, Colantoni C, Rancoita PMV, Baratto F, Di Serio C, Rizzo G, De Cobelli F, Della Bella P, Del Maschio A (2016) Cardiac CT with delayed enhancement in the characterization of ventricular tachycardia structural substrate: relationship between CT-segmented scar and electro-anatomic mapping. JACC Cardiovasc Imaging 9(7):822–832
Aikawa T, Oyama-Manabe N, Naya M, Ohira H, Sugimoto A, Tsujino I, Obara M, Manabe O, Kudo K, Tsutsui H, Tamaki N (2017) Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: a feasibility study. Eur Radiol 27(10):4054–4063
Ellims AH, Shaw JA, Stub D, Iles LM, Hare JL, Slavin GS, Kaye DM, Taylor AJ (2014) Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness. J Am Coll Cardiol 63:1112–1118
Vita T, Gräni C, Abbasi SA, Neilan TG, Rowin E, Kaneko K, Coelho-Filho O, Watanabe E, Mongeon FP, Farhad H, Rassi CH, Choi YL, Cheng K, Givertz MM, Blankstein R, Steigner M, Aghayev A, Jerosch-Herold M, Kwong RY (2018) Comparing CMR mapping methods and myocardial patterns toward heart failure outcomes in nonischemic dilated cardiomyopathy. JACC Cardiovasc Imaging 12:1659–1669
Palmisano A, Vignale D, Benedetti G, Del Maschio A, De Cobelli F, Esposito A (2020) Late iodine enhancement cardiac computed tomography for detection of myocardial scars: impact of experience in the clinical practice. Radiol Med. 125(2):128–136. https://doi.org/10.1007/s11547-019-01108-7
Nacif MS, Kawel N, Lee JJ, Chen X, Yao J, Zavodni A, Sibley CT, Lima JAC, Liu S, Bluemke DA (2012) Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology 264(3):876–883
Esposito A, Palmisano A, Barbera M, Vignae D, Benedetti G, Spoladore R, Ancona MB, Giannini F, Oppizzi M, Del Maschio A, De Cobelli F (2018) Cardiac computed tomography in troponin-positive chest pain: sometimes the answer lies in the late iodine enhancement or extracellular volume fraction map. JACC Cardiovasc Imaging 12:745–748
Lewin S, Goldberg L, Dec GW (2000) The spectrum of pulmonary abnormalities on computed chest tomographic imaging in patients with advanced heart failure. Am J Cardiol 86:98–100
Erly WK, Borders RJ, Outwater EK, Zaetta JM, Borders GT (2003) Location, size, and distribution of mediastinal lymph node enlargement in chronic congestive heart failure. J Comput Assist Tomogr 27:485–489
Melenovsky V, Andersen MJ, Andress K, Reddy YN, Borlaug BA (2015) Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications. Eur J Heart Fail 17:1161–1171
Chase SC, Taylor BJ, Cross TJ, Coffman KE, Olson LJ, Johnson BD (2017) Influence of thoracic fluid compartments on pulmonary congestion in chronic heart failure. J Card Fail 23:690–696
Huang W, Kingsbury MP, Turner MA, Donnelly JL, Flores NA, Sheridan DJ (2001) Capillary filtration is reduced in lungs adapted to chronic heart failure: morphological and haemodynamic correlates. Cardiovasc Res 49:207–217
Townsley MI, Fu Z, Mathieu-Costello O, West JB (1995) Pulmonary microvascular permeability. Responses to high vascular pressure after induction of pacing-induced heart failure in dogs. Circ Res 77:317–325
Gustafsson M, Alehagen U, Johansson P (2015) Imaging congestion with a pocket ultrasound device: prognostic implications in patients with chronic heart failure. J Card Fail 21:548–554
Coiro S, Rossignol P, Ambrosio G et al (2015) Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17:1172–1181
Chase SC, Wheatley CM, Olson LJ et al (2016) Impact of chronic systolic heart failure on lung structure-function relationships in large airways. Physiol Rep 4:e12867
Colin GC, Gerber BL, deMeesterdeRavenstein C et al (2018) Pulmonary hypertension due to left heart disease: diagnostic and prognostic value of CT in chronic systolic heart failure. Eur Radiol 28:4643–4653
Funding
There is no funding source.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest. No benefits have been or will be received from a commercial party related directly or indirectly to the subject matter of this article.
Ethical approval
This article does not contain any studies with animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Di Cesare, E., Carerj, S., Palmisano, A. et al. Multimodality imaging in chronic heart failure. Radiol med 126, 231–242 (2021). https://doi.org/10.1007/s11547-020-01245-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-020-01245-4